Outlook Therapeutics (OTLK) Net Margin Growth (1y) (2016 - 2019)
Outlook Therapeutics (OTLK) Net Margin Growth (1y) (2016 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4,168.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 673.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2,208.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -1,652.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,636.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -392.00 |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 146,355.00 |
| Jun 30, 2019 | 38,921.00 |
| Mar 31, 2019 | -65,218.00 |
| Dec 31, 2018 | 136,988.00 |
| Sep 30, 2018 | -137,865.00 |
| Jun 30, 2018 | 58,180.00 |
| Mar 31, 2018 | 154,548.00 |
| Dec 31, 2017 | 400,373.00 |
| Sep 30, 2017 | 187,524.00 |
| Jun 30, 2017 | 434,248.00 |
| Mar 31, 2017 | -219,459.00 |
| Dec 31, 2016 | -451,070.00 |
| Sep 30, 2016 | 155,705.00 |
| Jun 30, 2016 | -514,114.00 |
| Mar 31, 2016 | 258,821.00 |